NCT06115590View on ClinicalTrials.gov

Novel Objective Digital Biomarkers for Assessing Sub-clinical Mood Disturbances in the Singaporean Population

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

February 18, 2024

Study Completion Date

February 18, 2024

Conditions

Mood

Interventions

DIETARY_SUPPLEMENT

Nutritional supplement

Nutritional intervention hypothesized to have an acute anxiolytic effect

Trial Locations (1)

117609

Singapore Institute for Clinical Trials, Singapore

All Listed Sponsors

collaborator

OBVIO HEALTH USA, Inc.

UNKNOWN

lead

Institute for Human Development and Potential (IHDP), Singapore

OTHER

NCT06115590 - Novel Objective Digital Biomarkers for Assessing Sub-clinical Mood Disturbances in the Singaporean Population | Biotech Hunter | Biotech Hunter